Why is Evoq Remedies falling/rising?

As of 01-October, Evoq Remedies Ltd is experiencing a decline in its stock price, currently at 3.90, which reflects a decrease of 0.05 or 1.27%. The stock has been underperforming, having lost 14.85% over the last four days, and it has underperformed its sector by 2.63% today. In terms of longer-term performance, the stock has seen a significant drop of 50% year-to-date and a staggering 75.62% decline over the past three years. While the stock is currently trading above its 50-day moving average, it remains below the 5-day, 20-day, 100-day, and 200-day moving averages, indicating a bearish trend. The rising investor participation, with a 32.35% increase in delivery volume, suggests some interest, but the overall sentiment remains negative.
In the broader market context, the Sensex has only declined by 0.90% over the past week, contrasting sharply with Evoq Remedies' 12.56% drop in the same period. This indicates that the stock is not only underperforming relative to the market but also struggling significantly compared to its benchmark. The year-to-date performance further highlights this disparity, with the Sensex gaining 3.64% while Evoq Remedies has plummeted by 50%. Overall, the stock's recent movement reflects a combination of negative sentiment, poor performance metrics, and a lack of positive factors to counterbalance the ongoing declines.